FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2119366998> ?p ?o ?g. }

• W2119366998 endingPage "6266" @default.
• W2119366998 startingPage "6251" @default.
• W2119366998 abstract "The purpose of this article is to provide updated recommendations for the treatment of patients with stage IV non-small-cell lung cancer. A literature search identified relevant randomized trials published since 2002. The scope of the guideline was narrowed to chemotherapy and biologic therapy. An Update Committee reviewed the literature and made updated recommendations. One hundred sixty-two publications met the inclusion criteria. Recommendations were based on treatment strategies that improve overall survival. Treatments that improve only progression-free survival prompted scrutiny of toxicity and quality of life. For first-line therapy in patients with performance status of 0 or 1, a platinum-based two-drug combination of cytotoxic drugs is recommended. Nonplatinum cytotoxic doublets are acceptable for patients with contraindications to platinum therapy. For patients with performance status of 2, a single cytotoxic drug is sufficient. Stop first-line cytotoxic chemotherapy at disease progression or after four cycles in patients who are not responding to treatment. Stop two-drug cytotoxic chemotherapy at six cycles even in patients who are responding to therapy. The first-line use of gefitinib may be recommended for patients with known epidermal growth factor receptor (EGFR) mutation; for negative or unknown EGFR mutation status, cytotoxic chemotherapy is preferred. Bevacizumab is recommended with carboplatin-paclitaxel, except for patients with certain clinical characteristics. Cetuximab is recommended with cisplatin-vinorelbine for patients with EGFR-positive tumors by immunohistochemistry. Docetaxel, erlotinib, gefitinib, or pemetrexed is recommended as second-line therapy. Erlotinib is recommended as third-line therapy for patients who have not received prior erlotinib or gefitinib. Data are insufficient to recommend the routine third-line use of cytotoxic drugs. Data are insufficient to recommend routine use of molecular markers to select chemotherapy." @default.
• W2119366998 created "2016-06-24" @default.
• W2119366998 creator A5000551568 @default.
• W2119366998 creator A5005775817 @default.
• W2119366998 creator A5015581478 @default.
• W2119366998 creator A5018127054 @default.
• W2119366998 creator A5018401879 @default.
• W2119366998 creator A5019651161 @default.
• W2119366998 creator A5022063365 @default.
• W2119366998 creator A5046345302 @default.
• W2119366998 creator A5050185260 @default.
• W2119366998 creator A5052336062 @default.
• W2119366998 creator A5052461112 @default.
• W2119366998 creator A5054848999 @default.
• W2119366998 creator A5062616992 @default.
• W2119366998 creator A5065504460 @default.
• W2119366998 creator A5069416760 @default.
• W2119366998 creator A5071796883 @default.
• W2119366998 creator A5076002155 @default.
• W2119366998 creator A5077893229 @default.
• W2119366998 creator A5087391729 @default.
• W2119366998 date "2009-12-20" @default.
• W2119366998 modified "2023-10-13" @default.
• W2119366998 title "American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer" @default.
• W2119366998 cites W1496563114 @default.
• W2119366998 cites W1821505516 @default.
• W2119366998 cites W1968765750 @default.
• W2119366998 cites W1970232026 @default.
• W2119366998 cites W1970476748 @default.
• W2119366998 cites W1977657955 @default.
• W2119366998 cites W1982397643 @default.
• W2119366998 cites W1982635038 @default.
• W2119366998 cites W1988338874 @default.
• W2119366998 cites W1988442083 @default.
• W2119366998 cites W1994567819 @default.
• W2119366998 cites W2001650918 @default.
• W2119366998 cites W2001780500 @default.
• W2119366998 cites W2003260377 @default.
• W2119366998 cites W2009481811 @default.
• W2119366998 cites W2010758045 @default.
• W2119366998 cites W2012699859 @default.
• W2119366998 cites W2014330130 @default.
• W2119366998 cites W2016156617 @default.
• W2119366998 cites W2016717983 @default.
• W2119366998 cites W2018802677 @default.
• W2119366998 cites W2030864655 @default.
• W2119366998 cites W2032332769 @default.
• W2119366998 cites W2046510435 @default.
• W2119366998 cites W2048538776 @default.
• W2119366998 cites W2051786446 @default.
• W2119366998 cites W2052335855 @default.
• W2119366998 cites W2053432470 @default.
• W2119366998 cites W2053519484 @default.
• W2119366998 cites W2060349413 @default.
• W2119366998 cites W2060608817 @default.
• W2119366998 cites W2065521652 @default.
• W2119366998 cites W2068995289 @default.
• W2119366998 cites W2069312070 @default.
• W2119366998 cites W2070536874 @default.
• W2119366998 cites W2070558913 @default.
• W2119366998 cites W2071161965 @default.
• W2119366998 cites W2074459357 @default.
• W2119366998 cites W2077383408 @default.
• W2119366998 cites W2077520669 @default.
• W2119366998 cites W2077653686 @default.
• W2119366998 cites W2079123814 @default.
• W2119366998 cites W2086025400 @default.
• W2119366998 cites W2087764235 @default.
• W2119366998 cites W2088407876 @default.
• W2119366998 cites W2088720324 @default.
• W2119366998 cites W2090528807 @default.
• W2119366998 cites W2093922887 @default.
• W2119366998 cites W2095992216 @default.
• W2119366998 cites W2096289704 @default.
• W2119366998 cites W2097407664 @default.
• W2119366998 cites W2098158939 @default.
• W2119366998 cites W2099072173 @default.
• W2119366998 cites W2099725888 @default.
• W2119366998 cites W2100377347 @default.
• W2119366998 cites W2100785570 @default.
• W2119366998 cites W2101035251 @default.
• W2119366998 cites W2101625270 @default.
• W2119366998 cites W2103774839 @default.
• W2119366998 cites W2104265571 @default.
• W2119366998 cites W2104300284 @default.
• W2119366998 cites W2104620569 @default.
• W2119366998 cites W2105304787 @default.
• W2119366998 cites W2105834225 @default.
• W2119366998 cites W2106585301 @default.
• W2119366998 cites W2107183277 @default.
• W2119366998 cites W2107304950 @default.
• W2119366998 cites W2107686167 @default.
• W2119366998 cites W2107791134 @default.
• W2119366998 cites W2108912949 @default.
• W2119366998 cites W2109063316 @default.
• W2119366998 cites W2110835998 @default.
• W2119366998 cites W2111179508 @default.
• W2119366998 cites W2111479968 @default.

• next